Skip to content

Title 22 — Foreign Relations and Intercourse

Part A · Chapter 83 — United States Leadership Against Hiv/aids, Tuberculosis, and Malaria

§ 7636. Study on illegal diversions of prescription drugs

Statutory text

Not later than 180 days after , the Secretary of Health and Human Services, in coordination with other agencies, shall submit a report to the Congress that includes the following:

(1)

A thorough accounting of evidence indicating illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts, and an estimate of the extent of such diversion.

(2)

Recommendations to increase the administrative and enforcement powers of the United States to identify, monitor, and prevent the illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts.

(3)

Recommendations and guidelines to advise and provide technical assistance to developing countries on how to implement a program that minimizes diversion into the United States of prescription drugs donated or sold for humanitarian efforts.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003

    Pub. L. 108–25 title III § 307 · 117 Stat. 711

    Enacted · 22 U.S.C. § 7636

    (Pub. L. 108–25, title III, § 307, May 27, 2003, 117 Stat. 740.)

    Source evidence

    Code source credit
    (Pub. L. 108–25, title III, § 307, May 27, 2003, 117 Stat. 740.)

    Enacted provision · exact public law section
    SEC. 307. STUDY ON ILLEGAL DIVERSIONS OF PRESCRIPTION DRUGS.   Not later than Deadline. Reports. 180 days after enactment of this Act, the Secretary of Health and Human Services, in coordination with other agencies, shall submit a report to the Congress that includes the following: (1) A thorough accounting of evidence indicating illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts, and an estimate of the extent of such diversion. (2) Recommendations to increase the administrative and enforcement powers of the United States to identify, monitor, and prevent the illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts. (3) Recommendations and guidelines to advise and provide technical assistance to developing countries on how to implement a program that minimizes diversion into the United States of prescription drugs donated or sold for humanitarian efforts.

1 of 1 references resolved to an enrolled provision

Credits

(Pub. L. 108–25, title III, § 307, , 117 Stat. 740.)

Parsed from the official OLRC USLM XML in data/usc_all/usc22.xml · release point 119-108 · OLRC build 2026-09-09

USLM identifier /us/usc/t22/s7636